New Zealand markets open in 21 minutes
  • NZX 50

    12,628.89
    -165.71 (-1.30%)
     
  • NZD/USD

    0.6830
    -0.0028 (-0.40%)
     
  • ALL ORDS

    7,599.90
    -137.00 (-1.77%)
     
  • OIL

    68.17
    -10.22 (-13.04%)
     
  • GOLD

    1,792.30
    +8.00 (+0.45%)
     

3 Biotech Stocks That Are Ridiculously Overpriced

·6-min read
3 Biotech Stocks That Are Ridiculously Overpriced

Beauty is in the eye of the beholder -- and, in many cases, so is the appropriate valuation of a stock. Here's why they picked Cassava Sciences (NASDAQ: SAVA), Ocugen (NASDAQ: OCGN), and Moderna (NASDAQ: MRNA). Prosper Junior Bakiny (Cassava Sciences): Investors have been flocking to this clinical-stage biotech all year long, pushing its share price up by well over 600%.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting